Szilard Voros, MD, talks about the three factors that are included in the DPMP test and how they overlap but are separate from the CV data reports. Other videos with Dr. Voros: Szilard Voros, MD, FACC, FSCCT, FAHA: Introduction New Panel of Tests (DPMP) Identifies Diabetes and CV Risk Earlier …

Szilard Voros, MD, talks about the DPMP test that Health Diagnostics Laboratory has developed and how the insurance companies are handling the new tests. Other videos with Dr. Voros: Szilard Voros, MD, FACC, FSCCT, FAHA: Introduction New Panel of Tests (DPMP) Identifies Diabetes and CV Risk Earlier Beta-cell Dysfunction Not …

Szilard Voros, MD, discusses the drug Cycloset (a central dopamine agonist) and its possibilities for improving both cardiovascular and diabetic health. He talks about how Health Diagnostics Laboratory sees a very specific role and niche for this particular drug because of a specific biomarker they have identified. Other videos with Dr. …

  Szilard Voros, MD, discusses what he found the most interesting at the 2013 ADA and singles out the new SGLT2 inhibitor class of drugs as especially exciting. However, he cautions that they are very new and only time will tell regarding any safety aspects. He is intrigued by the concept …